Project Grant HT94252410700
Award Date
7/1/24
Completion Date
6/30/27
Dollars Obligated
$866K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Boston, MA 02118, USA
Similar Awards
This $1,635,000 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) supports research by the Trustees of Boston University to study the role of circular RNA in regulating host defense against bacterial sepsis and lung injury. The 4-year award, effective April 1, 2025, will enable Boston University researchers to conduct innovative biomedical investigations related to these critical medical challenges. As a leading...
The U.S. Department of Defense's Military Medical Research and Development program (CFDA 12.420) awarded a $330,000 project grant to Trustees of Boston University, doing business as the Boston University Medical Campus. The grant, awarded on March 15, 2024, will fund research to enhance lymphatic function using transplanted muscle cells after bacterial infection. The research aims to improve medical care for military service members, veterans, and their families. Boston University, a leading...
The Defense Health Agency awarded a $1,003,336 Project Grant to Trustees of Boston University under the Military Medical Research and Development program (CFDA 12.420) to investigate the "CONTRIBUTION OF CELLULAR SENESCENCE AND BRAIN AGING TO COGNITIVE DYSFUNCTION IN GWI" over a 3-year period from September 2023 to September 2026. As a leading private research institution, Boston University's Trustees will conduct biomedical research to transform healthcare for Service Members,...
The Trustees of Boston University will receive $330,000 from the Defense Health Agency under a Project Grant award to identify receptors for TDP-43 that mediate cellular uptake and neurotoxicity. This research is being conducted under the Military Medical Research and Development program (CFDA 12.420), which supports basic, applied, and advanced biomedical research to transform military and public health care through innovative medical solutions for battlefield injuries and other health...
The U.S. Defense Health Agency awarded a $646,252 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to Trustees of Boston University. The grant, awarded on June 1, 2024, funds a 3-year research project to uncover cell intrinsic and extrinsic factors governing melanoma dormancy at single-cell resolution.
The award includes a $45,500 sub-grant to the University of Virginia to provide academic and technical resources, under the supervision of Dr. Mohammad...
The Defense Health Agency awarded a $522,477 Project Grant to Boston Medical Center Corporation (BMC) under the Military Medical Research and Development program (CFDA 12.420). The funding will support research to define genetic vulnerabilities in pancreatic neuroendocrine tumors that rely on the alternative lengthening of telomeres pathway. This 3-year project grant runs from August 1, 2023 to July 31, 2026.
A sub-award of an unspecified amount was provided to the Trustees of Boston...
This $1,704,652 Project Grant award from the Department of Defense's Military Medical Research and Development program (CFDA 12.420) will fund research led by the Trustees of Boston University Medical Campus to investigate the translational impact of genetic susceptibility to complex toxic exposures on blood-brain barrier function and age-related neurological outcomes in Gulf War Illness. The research, spanning September 2024 to August 2027, aims to advance scientific understanding of the...
The Defense Health Agency awarded a $781,300.00 Project Grant titled "RELATIONSHIP OF METAL EXPOSURES TO HEALTH RISK MARKERS, MOOD, AND COGNITIVE FUNCTIONING IN MILITARY VETERANS" to Trustees of Boston University Medical Campus. The grant, funded under the Military Medical Research and Development program (CFDA 12.420), will support research to investigate the relationship between metal exposures, health risk indicators, mood, and cognitive functioning in military veterans....
The Department of Defense's Defense Health Agency awarded a $558,832 Project Grant to Tufts University School of Medicine under the Military Medical Research and Development program (CFDA 12.420) on September 30, 2024. This grant will support research focused on "Targeting Differentiation Epitope in CD11b of Tumor-Associated Inflammatory Monocytes: A Novel Adjuvant Dendritic Cell Therapy Approach for Mucosal Melanoma." The research aims to develop an innovative dendritic cell-based...
The Defense Health Agency has awarded a $657,263 project grant under the Military Medical Research and Development program (CFDA 12.420) to the Dana-Farber Cancer Institute, Inc. (d.b.a. DFCI) in Boston, MA. The award, effective September 1, 2024 through August 31, 2027, will support DATA-DRIVEN BIOMARKER-INFORMED DECISION ANALYTICS IN MELANOMA: IMPROVING EFFICACY AND REDUCING TOXICITY OF IMMUNE CHECKPOINT BLOCKADE. Through this grant, DFCI will conduct research to develop data-driven...